Safety and Efficacy of a Dapivirine Vaginal Ring for HIV Prevention in Women

Publish Year : 2016
Publisher : New England Journal of Medicine
Author Name : Nel A., van Niekerk N., Kapiga S., Bekker L.G., Gama C., Gill K., Kamali A., Kotze P., Louw C., Mabude Z., Miti N., Kusemererwa S., Tempelman H., Carstens H., Devlin B., Isaacs M., Malherbe M., Mans W., Nuttall J., Russell M., Ntshele S., Smit M., Solai L., Spence P., Steytler J., Windle K., Borremans M., Resseler S., Van Roey J., Parys W., Vangeneugden T., Van Baelen B., and Rosenberg Z.
Link : Click here

Description :

This article evaluates the safety and efficacy of a vaginal ring containing dapivirine for the prevention of HIV infection in nearly 2,000 women of reproductive age from South Africa and Uganda. The study was a randomized, double-blind, placebo-controlled trial and it found that the dapivirine ring was not associated with any safety concerns and was associated with a lower rate of HIV-1 infection than the placebo rate.

Recent Resource

Start Free, Stay Free, AIDS Free

Ending the AIDS epidemic among children, adolescents and young women requires ambitious targets and...

Walking in Our Shoes: Perspectives of Pregnant and Breastfeeding Women living with HIV

This community-led study in Malawi, Uganda and Zambia sought to understand the factors that...

International Technical Guidance on Sexuality Education: An Evidence-Informed Approach

This updated guidance promotes health and well-being, respect for human rights and gender equality...

View More